Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Sell
38
HLOSF Quote, Financials, Valuation and Earnings
Last price:
$2.10
Seasonality move
:
11.4%
Day range:
$2.10 - $2.10
52-week range:
$0.96 - $4.45
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
329.74x
P/B ratio:
12.23x
Volume:
--
Avg. volume:
23
1-year change:
118.75%
Market cap:
$243M
Revenue:
$3.7M
EPS (TTM):
-$0.26
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Healios KK has -- downside to fair value with a price target of -- per share.
HLOSF vs. S&P 500
-
Over the past 5 trading days, Healios KK has overperformed the S&P 500 by 1.41% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Healios KK does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Healios KK revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Healios KK reported revenues of $128.8K.
Earnings Growth
-
Healios KK has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Healios KK reported earnings per share of $0.03.
Enterprise value:
217M
EV / Invested capital:
--
Price / LTM sales:
329.74x
EV / EBIT:
--
EV / Revenue:
334.54x
PEG ratio (5yr expected):
-0.14x
EV / Free cash flow:
-10.91x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$2.4M
Return On Assets:
-25.3%
Net Income Margin (TTM):
-4043.82%
Return On Equity:
-194.37%
Return On Invested Capital:
-86.08%
Operating Margin:
-4022.21%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1.3M | $3.5M | $648.5K | $227.8K | $128.9K | |
| Gross Profit | -$426.1K | $2M | -$2.4M | -$455.7K | -$637.6K | |
| Operating Income | -$24.4M | -$20.9M | -$21.9M | -$4.4M | -$5.2M | |
| EBITDA | -$21.5M | -$19.9M | -$20M | -$4M | -$4.7M | |
| Diluted EPS | -$0.37 | -$0.50 | -$0.26 | -$0.11 | $0.03 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $160.8M | $56.2M | $70.7M | $35.5M | $48.6M | |
| Total Assets | $233.6M | $103.1M | $120.4M | $89.1M | $117.3M | |
| Current Liabilities | $61.2M | $4.5M | $50.6M | $27.8M | $36.7M | |
| Total Liabilities | $139M | $71.3M | $82.8M | $76.9M | $97.3M | |
| Total Equity | $94.6M | $31.7M | $37.7M | $12.2M | $20M | |
| Total Debt | $104.7M | $49.5M | $47.6M | $14.5M | $17.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$17.8M | -$15.5M | -$19.4M | -$944.8K | -$4.9M | |
| Cash From Investing | -$8.1M | -$4.5M | -$10.5M | -$13.4K | -$286K | |
| Cash From Financing | $43.1M | -$13.8M | $43.4M | -$27M | $6.4M | |
| Free Cash Flow | -$18.1M | -$17.5M | -$19.9M | -$971.6K | -$5.3M | |
HLOSF
Sector
Market Cap
$243M
$24M
Price % of 52-Week High
47.19%
48.29%
Dividend Yield
0%
0%
Shareholder Yield
-6.12%
-1.62%
1-Year Price Total Return
118.75%
-22.92%
Beta (5-Year)
0.262
0.500
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$2.10
200-day SMA
Sell
Level
$3.10
Bollinger Bands (100)
Sell
Level
2.11 - 3.69
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$2.10
Relative Strength Index (RSI14)
Sell
Level
39.76
ADX Line
Neutral
Level
Williams %R
Sell
Level
0
50-day SMA
Sell
Level
$2.19
MACD (12, 26)
Buy
Level
0.55
25-day Aroon Oscillator
Buy
Level
20
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.4213)
Sell
CA Score
(Annual)
Level (-2.6805)
Buy
Beneish M-Score
(Annual)
Level (-2.4113)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (4.9808)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Healios KK engages in the research, development, and sale of cellular and regenerative medicine. It develops therapies for ischemic stroke, acute respiratory distress syndrome, liver disease, and age-regulated macular degeneration. The company was founded by Tadahisa Kagimoto on February 24, 2011 and is headquartered in Tokyo, Japan.
Stock Forecast FAQ
In the current month, HLOSF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HLOSF average analyst price target in the past 3 months is --.
-
Where Will Healios KK Stock Be In 1 Year?
According to analysts, the consensus estimate is that Healios KK share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Healios KK?
Analysts are divided on their view about Healios KK share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Healios KK is a Sell and believe this share price will rise from its current level to --.
-
What Is Healios KK's Price Target?
The price target for Healios KK over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HLOSF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Healios KK is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of HLOSF?
You can purchase shares of Healios KK via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Healios KK shares.
-
What Is The Healios KK Share Price Today?
Healios KK was last trading at $2.10 per share. This represents the most recent stock quote for Healios KK. Yesterday, Healios KK closed at $2.10 per share.
-
How To Buy Healios KK Stock Online?
In order to purchase Healios KK stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get HLOSF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HLOSF
Sector
P/E ratio
--
23.44x
PEG ratio
-0.14x
-0.01x
P/B ratio
12.23x
1.73x
Price / LTM sales
329.74x
1.51x
Growth Metrics
HLOSF
Sector
Revenue growth
-43.45%
3.31%
Earnings growth
129.04%
10.7%
Revenue (5-year growth)
35.26%
6.28%
Earnings forecast
--
-$0.19
Profitability
HLOSF
Sector
Profitability FY 2024
$891.1K
$2.6M
Return on invested capital
-86.08%
-33.62%
Return on assets
-25.3%
-29.74%
Return on equity
-194.37%
-39.33%
Earnings Date
Last Earnings Date
Feb
15
Next Earnings Date
Feb
15
Estimated Next Earnings Date
May
17
Balance Sheet
HLOSF
Sector
Total cash
$44M
$25M
Short term investments
--
$23.9M
Total assets
$90.3M
$71.9M
Long term debt
$17.8M
$2.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Is Sandisk The Next Big Memory Stock?
Computer memory manufacturer Sandisk (NASDAQ:SNDK) has quietly been one of…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
77
CPS alert for Feb 14
Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.
Buy
58
TPH alert for Feb 14
Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.
Sell
20
IRON alert for Feb 14
Disc Medicine, Inc. [IRON] is down 21.88% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
